PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 4, 2024CA A Cancer Journal for Clinicians25,401 citationsOpen Access

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

View Full Paper
FBFreddie BrayPublic Library of ScienceMLMathieu LaversanneWorld Health OrganizationHSHyuna SungAmerican Cancer Society

Key Points

  • Cancer incidence reached nearly 20 million new cases globally in 2022, highlighting a significant public health challenge.
  • Lung cancer accounted for approximately 2.5 million cases, making it the most frequently diagnosed cancer worldwide with a high mortality rate.
  • Geographic variability in incidence rates was noted, with Australia/New Zealand having over 500 cases per 100,000 population among men and under 100 in Western Africa, reflecting disparities in healthcare access and lifestyle factors. International predictions indicate that new cancer cases could rise to 35 million by 2050; addressing key risk factors is crucial for future prevention efforts.

Abstract

Abstract This article presents global cancer statistics by world region for the year 2022 based on updated estimates from the International Agency for Research on Cancer (IARC). There were close to 20 million new cases of cancer in the year 2022 (including nonmelanoma skin cancers NMSCs) alongside 9.7 million deaths from cancer (including NMSC). The estimates suggest that approximately one in five men or women develop cancer in a lifetime, whereas around one in nine men and one in 12 women die from it. Lung cancer was the most frequently diagnosed cancer in 2022, responsible for almost 2.5 million new cases, or one in eight cancers worldwide (12.4% of all cancers globally), followed by cancers of the female breast (11.6%), colorectum (9.6%), prostate (7.3%), and stomach (4.9%). Lung cancer was also the leading cause of cancer death, with an estimated 1.8 million deaths (18.7%), followed by colorectal (9.3%), liver (7.8%), female breast (6.9%), and stomach (6.8%) cancers. Breast cancer and lung cancer were the most frequent cancers in women and men, respectively (both cases and deaths). Incidence rates (including NMSC) varied from four‐fold to five‐fold across world regions, from over 500 in Australia/New Zealand (507.9 per 100,000) to under 100 in Western Africa (97.1 per 100,000) among men, and from over 400 in Australia/New Zealand (410.5 per 100,000) to close to 100 in South‐Central Asia (103.3 per 100,000) among women. The authors examine the geographic variability across 20 world regions for the 10 leading cancer types, discussing recent trends, the underlying determinants, and the prospects for global cancer prevention and control. With demographics‐based predictions indicating that the number of new cases of cancer will reach 35 million by 2050, investments in prevention, including the targeting of key risk factors for cancer (including smoking, overweight and obesity, and infection), could avert millions of future cancer diagnoses and save many lives worldwide, bringing huge economic as well as societal dividends to countries over the forthcoming decades.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bray et al. (2024) studied this question.

synapsesocial.com/papers/68e7055ab6db64358767f8f5https://doi.org/10.3322/caac.21834
Ask AI
Helpful
Bookmark
Share
View Full Paper